Covid-19 Vaccine Janssen 0.5 mL Suspension for injection (injection).
PDF Leaflet Revision Date: 14 April 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Active immunisation to prevent COVID-19 in individuals 18 years and older.
Dosage (summary)
Single dose of 0.5 mL by intramuscular injection; booster at least 2 months later.
Special Populations
- Elderly
- Immunocompromised
Pregnancy & Breastfeeding
Safety in pregnancy not established; no data on excretion in breast milk.
Key Drug Interactions
- Other vaccines (do not mix in same syringe)
Contraindications
- Hypersensitivity to active substance or excipients
- History of thrombosis with thrombocytopenia syndrome
- Capillary leak syndrome
Common side effects
- Injection site pain
- Headache
- Fatigue
- Myalgia
- Nausea
Counselling Points
- Monitor for 15 mins post-vaccination
- Report any severe allergic reactions
- Avoid vaccination during acute illness
Serious warnings
- Anaphylaxis risk
- Thrombosis with thrombocytopenia syndrome
- Venous thromboembolism
Important Disclaimer
The Covid-19 Vaccine Janssen 0.5 mL Suspension for injection (injection). professional information leaflet below is the property of Janssen Pharmaceutica and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
